Central Forest Group, Inc. (XNGO:7675)

Inozyme Pharma Statistics

Total Valuation

XNGO:7675 has a market cap or net worth of JPY 22.16 billion. The enterprise value is 5.25 billion.

Market Cap	22.16B
Enterprise Value	5.25B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Dec 29, 2025

Share Statistics

XNGO:7675 has 8.18 million shares outstanding. The number of shares has decreased by -2.35% in one year.

Current Share Class	8.18M
Shares Outstanding	8.18M
Shares Change (YoY)	-2.35%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	13.61%
Owned by Institutions (%)	8.17%
Float	1.50M

Valuation Ratios

The trailing PE ratio is 10.18.

PE Ratio	10.18
Forward PE	n/a
PS Ratio	0.06
PB Ratio	0.67
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.36
EV / Sales	0.01
EV / EBITDA	1.56
EV / EBIT	1.99
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.20

Current Ratio	1.20
Quick Ratio	0.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	292.89

Financial Efficiency

Return on equity (ROE) is 6.81% and return on invested capital (ROIC) is 5.05%.

Return on Equity (ROE)	6.81%
Return on Assets (ROA)	1.52%
Return on Invested Capital (ROIC)	5.05%
Return on Capital Employed (ROCE)	7.22%
Revenue Per Employee	457.16M
Profits Per Employee	2.85M
Employee Count	781
Asset Turnover	3.29
Inventory Turnover	31.08

Taxes

In the past 12 months, XNGO:7675 has paid 936.00 million in taxes.

Income Tax	936.00M
Effective Tax Rate	29.63%

Stock Price Statistics

The stock price has increased by +10.12% in the last 52 weeks. The beta is -0.10, so XNGO:7675's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	+10.12%
50-Day Moving Average	2,737.00
200-Day Moving Average	2,467.68
Relative Strength Index (RSI)	49.03
Average Volume (20 Days)	550

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XNGO:7675 had revenue of JPY 357.04 billion and earned 2.22 billion in profits. Earnings per share was 266.20.

Revenue	357.04B
Gross Profit	33.80B
Operating Income	2.64B
Pretax Income	3.16B
Net Income	2.22B
EBITDA	3.36B
EBIT	2.64B
Earnings Per Share (EPS)	266.20

Balance Sheet

The company has 10.57 billion in cash and n/a in debt, giving a net cash position of 10.57 billion or 1,292.52 per share.

Cash & Cash Equivalents	10.57B
Total Debt	n/a
Net Cash	10.57B
Net Cash Per Share	1,292.52
Equity (Book Value)	32.91B
Book Value Per Share	4,023.93
Working Capital	13.95B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 9.47%, with operating and profit margins of 0.74% and 0.62%.

Gross Margin	9.47%
Operating Margin	0.74%
Pretax Margin	0.88%
Profit Margin	0.62%
EBITDA Margin	0.94%
EBIT Margin	0.74%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.21%.

Dividend Per Share	60.00
Dividend Yield	2.21%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	2.35%
Shareholder Yield	4.57%
Earnings Yield	10.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XNGO:7675 has an Altman Z-Score of 4.05 and a Piotroski F-Score of 4.

Altman Z-Score	4.05
Piotroski F-Score	4